The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge
Clinical trial NCT01003301 · COMPLETED
Trial details
- NCT number
- NCT01003301
- Sponsor
- Johns Hopkins University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2012-12-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.